Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2006

01-03-2006 | Original Article

The N Ratio Predicts Recurrence and Poor Prognosis in Patients With Node-Positive Early Gastric Cancer

Authors: Jae-Ho Cheong, MD, Woo Jin Hyung, MD, Jian Guo Shen, MD, Changsoo Song, MD, Junuk Kim, MD, Seung Ho Choi, MD, Sung Hoon Noh, MD, PhD

Published in: Annals of Surgical Oncology | Issue 3/2006

Login to get access

Abstract

Background

The metastatic status of the regional node is the most significant prognostic factor for early gastric cancer (EGC). However, diverse prognoses are evident even among the same N classifications of the current tumor-node-metastasis system. The aim of this study was to evaluate the prognostic significance of the ratio of metastatic to retrieved lymph nodes (N ratio) in identifying a high-risk subgroup with node-positive EGC.

Methods

From a prospective database of 1264 EGC patients between 1987 and 1997, 156 (12.4%) were found to have histologically confirmed node metastasis. A number of prognostic factors, including the N ratio, were evaluated by univariate and multivariate analysis.

Results

The recurrence rate of node-positive EGC was 16.7% (n = 26). The overall 5-year survival rate of all patients was 84.0%. It was 26.9% and 95.4% in patients with and without recurrence, respectively (P < .0001; log-rank test). The cutoff value of the N ratio was set at .07. The 5-year survival rate of patients with an N ratio <.07 was 94.0%; this was significantly higher than the rate (72.6%) for those with a ratio >.07 (P < .0001; log-rank test). Both univariate and multivariate analysis identified the N ratio as the most significant predictive factor for recurrence and overall survival. Regarding stage migration, it shows superiority in comparison to the number-based N classification.

Conclusions

The N ratio is a more effective and rational indicator for prognostic stratification of patients with lymph node–positive EGC than the current N classification of the tumor-node-metastasis system.
Literature
1.
go back to reference Nakamura K, Ueyama T, Yao T, et al. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992;70:1030–7PubMed Nakamura K, Ueyama T, Yao T, et al. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer 1992;70:1030–7PubMed
2.
go back to reference Hioki K, Nakane Y, Yamamoto M. Surgical strategy for early gastric cancer. Br J Surg 1990;77:1330–4PubMed Hioki K, Nakane Y, Yamamoto M. Surgical strategy for early gastric cancer. Br J Surg 1990;77:1330–4PubMed
3.
go back to reference Matsusaka T, Kodama Y, Soejima K, et al. Recurrence in early gastric cancer: a pathologic evaluation. Cancer 1980;46:168–72PubMed Matsusaka T, Kodama Y, Soejima K, et al. Recurrence in early gastric cancer: a pathologic evaluation. Cancer 1980;46:168–72PubMed
4.
go back to reference Habu H, Takeshita K, Sunagawa M, Endo M. Lymph node metastasis in early gastric cancer. Int Surg 1986;71:244–7PubMed Habu H, Takeshita K, Sunagawa M, Endo M. Lymph node metastasis in early gastric cancer. Int Surg 1986;71:244–7PubMed
5.
go back to reference Sowa M, Kato Y, Nishimura M, Kudo T, Maekawa H, Umegawa K. Surgical approach to early gastric cancer with lymph node metastasis. World J Surg 1989;13:630–6CrossRefPubMed Sowa M, Kato Y, Nishimura M, Kudo T, Maekawa H, Umegawa K. Surgical approach to early gastric cancer with lymph node metastasis. World J Surg 1989;13:630–6CrossRefPubMed
6.
go back to reference Lawrence M, Shiu MH. Early gastric cancer. Twenty-eight-year experience. Ann Surg 1991;213:327–34PubMed Lawrence M, Shiu MH. Early gastric cancer. Twenty-eight-year experience. Ann Surg 1991;213:327–34PubMed
7.
go back to reference Jentschura D, Heubner C, Manegold BC, Rumstadt B, Winkler M, Trede M. Surgery for early gastric cancer: a European one-center experience. World J Surg 1997;21:845–8CrossRefPubMed Jentschura D, Heubner C, Manegold BC, Rumstadt B, Winkler M, Trede M. Surgery for early gastric cancer: a European one-center experience. World J Surg 1997;21:845–8CrossRefPubMed
8.
go back to reference Hochwald SN, Brennan MF, Klimstra DS, Kim S, Karpeh MS. Is lymphadenectomy necessary for early gastric cancer? Ann Surg Oncol 1999;6:664–70CrossRefPubMed Hochwald SN, Brennan MF, Klimstra DS, Kim S, Karpeh MS. Is lymphadenectomy necessary for early gastric cancer? Ann Surg Oncol 1999;6:664–70CrossRefPubMed
9.
go back to reference Gotoda T, Sasako M, Ono H, Katai H, Sano T, Shimoda T. Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer. Br J Surg 2001;88:444–9CrossRefPubMed Gotoda T, Sasako M, Ono H, Katai H, Sano T, Shimoda T. Evaluation of the necessity for gastrectomy with lymph node dissection for patients with submucosal invasive gastric cancer. Br J Surg 2001;88:444–9CrossRefPubMed
10.
go back to reference Roder JD, Bottcher K, Busch R, Wittekind C, Hermanek P, Siewert JR. Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer 1998;82:621–31CrossRefPubMed Roder JD, Bottcher K, Busch R, Wittekind C, Hermanek P, Siewert JR. Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer 1998;82:621–31CrossRefPubMed
11.
go back to reference Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 2003;10:1077–85. CrossRefPubMed Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 2003;10:1077–85. CrossRefPubMed
12.
go back to reference Hyung WJ, Noh SH, Yoo CH, et al. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 2002;26:323–9PubMed Hyung WJ, Noh SH, Yoo CH, et al. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 2002;26:323–9PubMed
13.
go back to reference Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002;9:775–84CrossRefPubMed Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002;9:775–84CrossRefPubMed
14.
go back to reference Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 2002;9:27–34CrossRefPubMed Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 2002;9:27–34CrossRefPubMed
15.
go back to reference Kodera Y, Yamamura Y, Shimizu Y, et al. Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM classification? Tumor Node Metastasis. J Surg Oncol 1998;69:15–20CrossRefPubMed Kodera Y, Yamamura Y, Shimizu Y, et al. Lymph node status assessment for gastric carcinoma: is the number of metastatic lymph nodes really practical as a parameter for N categories in the TNM classification? Tumor Node Metastasis. J Surg Oncol 1998;69:15–20CrossRefPubMed
16.
go back to reference Kodera Y, Yamamura Y, Shimizu Y, et al. Metastatic gastric lymph node rate is a significant prognostic factor for resectable stage IV stomach cancer. J Am Coll Surg 1997;185:65–9PubMed Kodera Y, Yamamura Y, Shimizu Y, et al. Metastatic gastric lymph node rate is a significant prognostic factor for resectable stage IV stomach cancer. J Am Coll Surg 1997;185:65–9PubMed
17.
go back to reference Siewert JR, Bittcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449–61CrossRefPubMed Siewert JR, Bittcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Ann Surg 1998;228:449–61CrossRefPubMed
18.
go back to reference Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery, pathology: part I. Jpn J Surg 1981;11:127–39 Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery, pathology: part I. Jpn J Surg 1981;11:127–39
19.
go back to reference Hermanek P, Sobin LH, eds. UICC TNM Classification of Malignant Tumours. 4th ed. New York: Springer-Verlag, 1992 Hermanek P, Sobin LH, eds. UICC TNM Classification of Malignant Tumours. 4th ed. New York: Springer-Verlag, 1992
20.
go back to reference Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours. 5th ed. New York: Wiley, 1997 Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumours. 5th ed. New York: Wiley, 1997
21.
go back to reference Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604–8PubMed Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604–8PubMed
22.
go back to reference Bonder BE. Will Rogers phenomenon and gastric carcinoma (letter). Arch Surg 1988;123:1023–4 Bonder BE. Will Rogers phenomenon and gastric carcinoma (letter). Arch Surg 1988;123:1023–4
Metadata
Title
The N Ratio Predicts Recurrence and Poor Prognosis in Patients With Node-Positive Early Gastric Cancer
Authors
Jae-Ho Cheong, MD
Woo Jin Hyung, MD
Jian Guo Shen, MD
Changsoo Song, MD
Junuk Kim, MD
Seung Ho Choi, MD
Sung Hoon Noh, MD, PhD
Publication date
01-03-2006
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 3/2006
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/ASO.2006.04.018

Other articles of this Issue 3/2006

Annals of Surgical Oncology 3/2006 Go to the issue